Aortic diseases Aortic diseases
Conditions
Interventions
Arm A: Iopromide 300 mgI/mL intravenously given and perform dual-energy CTA
Arm B: Iopromide 370 mgI/mL intravenously given and perform dual-energy CTA
Sponsors
Noda Yoshifumi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 18 years old (any men and women) 2. Planned for aortic CTA (screening or follow-up for aortic aneurysm, aortic dissection, etc.) 3. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Over 90 kg 2. Past history of hypersensitivity reaction to contrast material 3. pregnant woman 4. eGFR < 30 mL/min/1.73m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial visualization score for iliolumber artery on 3D VR images | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial visualization scores except for iliolumber artery (brachiocephalic, common carotid, subclavian, bronchial, internal thoracic, intercostal, common hepatic, proper hepatic, splenic, left gastric, gastroduodenal, inferior phrenic, superior mesenteric, inferior mesenteric, renal, lumbar, external iliac, internal iliac, superior gluteal, inferior gluteal, obturator, and inferior epigastric arteries) on 3d VR images and for all arteried described above on axial and coronal images, CT attenuations of arteries, image noise, signal-to-noise ratio, and image quality. | — |
Contacts
Public ContactYoshifumi Noda
Gifu University Hospital
Outcome results
None listed